about
The Wnt-dependent signaling pathways as target in oncology drug discoverySulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patientsPopulation pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjectscGMP-dependent protein kinase Iβ interacts with p44/WDR77 to regulate androgen receptor-driven gene expression.Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response studyNitric oxide donor exisulind is an effective inhibitor of murine photocarcinogenesisHereditary aspects of colon cancerExisulind in the treatment of prostate cancer.Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.Cyclic 3',5'-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia.PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues.
P2860
Q24652979-CF6C1488-E6EF-40CC-BA6F-C9A37429CCD3Q24794243-54C8448F-3FE0-4605-BAE1-98EBCC42169EQ33998845-6F305B04-3F01-4597-89C7-06074EDC0E1AQ34765533-8EBB9FF6-265A-4376-B58E-AB4F20956601Q35760255-E0A06E36-C23C-443C-B108-DBB2B37EC6D8Q36013003-D322F82C-D469-46B2-94A1-597D66E699A6Q36101834-E41CE91D-6EA7-40C1-A29B-71DBC93805FEQ36334866-E4EF7809-EF41-4A52-86CD-E0DD8205DF9EQ37082792-A1A80196-545E-4A1A-8CBE-43EC10BCECD2Q37855854-EB5EB693-C66A-4F64-BA7A-3EA5573F7C23Q39544460-5BBE3BD5-3C74-4CDF-9FA8-EF44661904D8Q39721627-BB8B3FE1-676A-4F28-A57B-E0E227FBB26DQ45254680-16B7D4D5-9658-4076-A204-0A9525C94E5D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Exisulind, a selective apoptotic antineoplastic drug.
@ast
Exisulind, a selective apoptotic antineoplastic drug.
@en
Exisulind, a selective apoptotic antineoplastic drug.
@nl
type
label
Exisulind, a selective apoptotic antineoplastic drug.
@ast
Exisulind, a selective apoptotic antineoplastic drug.
@en
Exisulind, a selective apoptotic antineoplastic drug.
@nl
prefLabel
Exisulind, a selective apoptotic antineoplastic drug.
@ast
Exisulind, a selective apoptotic antineoplastic drug.
@en
Exisulind, a selective apoptotic antineoplastic drug.
@nl
P2860
P1476
Exisulind, a selective apoptotic antineoplastic drug.
@en
P2093
Goluboff ET
P2860
P304
P356
10.1517/13543784.10.10.1875
P407
P577
2001-10-01T00:00:00Z